Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect on reduction of serum phosphate and the
safety of BAY77-1931 (lanthanum carbonate) in patients with hyperphosphatemia undergoing
continuous ambulatory peritoneal dialysis.